DA

Daivaras Anužis

Entrepreneur | Investor

📍 Singapore🔄 Updated November 2026💼 3 investments📅 11 years investing🗓 Last invested Jun 2024
Operator-angel🌍 Singapore
3
Total investments
0
Early stage
1
Mid stage
1
Late stage
11y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jun 2024
WE DO ACCOUNTING. JUST SMARTER. Efficient. Paperless. Powered by Artificial Intelligence.
Angel Investor
Oct 2020
LitBANs objective is to foster business angel activity through communication, events, networking, syndication of deals both locally and across Europe. The association’s key directions of activity: 1. Networking & start-up deal flow facilitation via monthly events 2. Private investor interest representation through a consistent dialogue with public officials and governmental institutions 3. Sharing of tools, legal frameworks and knowledge for the purpose of attracting new angel investors.
mid stage
Experience · 5 entries
All (5)
Investments (3)
Founder (2)
Board (2)
2024
Co-Founder
Sep 2024
Trialo is transforming drug development through AI-powered clinical evidence intelligence. Our platform automatically extracts and analyzes efficacy endpoints from regulatory submissions, scientific literature, company announcements, and public documents—enabling pharmaceutical companies, investors, and research organizations to make faster, more confident development decisions. Our comprehensive suite of tools includes: • DiseaseXplorer™ for indication-centric analytics • Smart Endpoint Analytics for standardized efficacy comparisons • AI Research Assistant for instant, evidence-based insights • Source Document Verification for regulatory-grade validation Through our advanced AI architecture and proprietary trial endpoint recognition technology, we process tens of thousands of clinical documents to deliver structured, actionable insights. Our platform helps clients compare drug efficacy across therapeutic areas, optimize trial designs, identify market opportunities, and generate regulatory-grade evidence summaries in minutes rather than months. Founded by veterans in drug development and AI engineering, were committed to accelerating innovation in life sciences by making clinical evidence more accessible and actionable than ever before. Specialties: Clinical Trial Analytics, Drug Development Intelligence, AI-Powered Research, Regulatory Intelligence, Clinical Evidence Analysis, Trial Design Optimization, Drug Efficacy Comparison, Market Assessment, Healthcare Technology.
Board Member
Jun 2024
WE DO ACCOUNTING. JUST SMARTER. Efficient. Paperless. Powered by Artificial Intelligence.
2022
Founder
Jun 2022
Moorio is a new generation digital marketplace for bunker fuel suppliers to instantly provide quotes, negotiate with customers and manage bunker fuel orders at any sea port. It is not just another software! It is an integrated one-stop solution for fully covering fuel ordering process. Create your free account and join Moorio network now: https://business.moorio.com/register/ www.moorio.com
2020
Angel Investor
Oct 2020
LitBANs objective is to foster business angel activity through communication, events, networking, syndication of deals both locally and across Europe. The association’s key directions of activity: 1. Networking & start-up deal flow facilitation via monthly events 2. Private investor interest representation through a consistent dialogue with public officials and governmental institutions 3. Sharing of tools, legal frameworks and knowledge for the purpose of attracting new angel investors.
mid stage
2015
Board Member
Oct 2015
GINDANA Bunkering & Trading is a leading fuel wholesale and bunker company in Lithuania. GINDANA was founded in 1995 and has been rapidly growing ever since. Our company pays great attention to our clients, their needs and close cooperating together, which makes it possible to maintain excellent relations with clients and ensure long-term cooperation.
Investment activity
2015–2024 · 3 investments
201512020120241
Recent (last 2 years)Earlier
Investor lists
Lists that match Daivaras's portfolio